General information notice
This article is intended for general education only. It does not replace individual medical advice, diagnosis, or consultation. Suitability for any treatment is assessed on a case-by-case basis following an in-clinic consultation.
“Not today” is sometimes the safest decision we make
In aesthetic medicine, good judgment matters as much as technical skill. There are times when the safest, most ethical decision is to delay or decline a procedure.
This is not about perfection. It is about safety, timing, accurate medical history, and practising within appropriate clinical standards.
Below are common scenarios where we may recommend postponing treatment.
1. An active cold sore or viral lesion
What we hear: “Its not near the area”
Why we pause:
Treating skin with an active viral lesion increases risk of spread, secondary infection, and delayed healing. Standard infection control and duty of care require caution.
What we do instead:
We defer treatment until the area has fully resolved. If appropriate, we may recommend discussing therapy with your GP.
2. Recent isotretinoin use (including overseas prescriptions)
What we hear: “It was prescribed overseas so I didn’t mention it.”
Why we pause:
Isotretinoin can affect skin barrier function and healing for some patients. Certain procedures may carry higher risk of irritation, scarring, or prolonged inflammation during or soon after a course.
What we do instead:
We assess your skin and timing carefully. Where postponement is recommended, we plan a safe re-entry point rather than rushing.
3. Recent facial surgery, dental surgery, or procedures still healing
What we hear: “It was only my jaw.”
Why we pause:
Recent surgery can temporarily alter anatomy, vascularity, swelling patterns, and tissue behaviour. Treating too soon can interfere with healing or distort outcomes.
What we do instead:
We may request surgical or dental clearance and recommend an appropriate interval before proceeding.
4. Blood thinners, anticoagulants, or supplements that affect bruising
What we hear: “Oh, you meant those.”
Why we pause:
Medications and some supplements can increase bruising and bleeding risk, and may change what is appropriate on the day.
What we do instead:
We review your list and plan appropriately, with clearance from your other practitioners if necessary In many cases treatment can still proceed, but only once risk is properly assessed.
5. Recent laser or energy-based procedures elsewhere
What we hear: “I had a laser yesterday, but iit was very light”
Why we pause:
After certain skin procedures, the barrier is temporarily compromised. Adding further procedures too soon can increase irritation, pigmentation risk, and delayed healing.
What we do instead:
We map timing properly. Where combined treatments are appropriate, they are planned and staged under one clinical framework.
6. Pregnancy and breastfeeding
What we hear: “My GP said it would be fine.”
Why we pause:
For many aesthetic procedures, there is limited safety data during pregnancy and breastfeeding. In the absence of strong evidence, we practise conservatively.
What we do instead:
We defer and support you with skin-safe options that are appropriate during this period.
7. Recent thread procedures with requests for immediate repeat treatment
What we hear: “They’re gone now, can I do more?”
Why we pause:
Threads require time for tissue settling and healing. Repeating too early can increase risk of inflammation, infection, irregularities, and poor tissue response.
What we do instead:
We follow recommended retreatment intervals and review healing before any further planning.
8. Incomplete allergy history or previous reactions
What we hear: “I forgot to mention that.”
Why we pause:
Allergy and reaction history can influence product selection, procedure suitability, and risk management.
What we do instead:
We take the time to clarify your history properly. If needed, we delay rather than proceed with uncertainty.
9. Unknown products or undocumented prior procedures
What we hear: “ I think it’s fine, it was a long time ago.”
Why we pause:
When prior products or procedures are undocumented, it can be difficult to predict tissue behaviour and risk. In some cases, proceeding without accurate records increases the chance of complications.
What we do instead:
We focus on assessment first. Where possible, we may request records, recommend imaging, or plan a cautious staged approach.
10. Overseas procedures without traceable details
What we hear: “I had it done overseas.”
Why we pause:
Different jurisdictions use different products, standards, and documentation. Without traceable details, risk can be harder to assess.
What we do instead:
We prioritise safety and clarity. Sometimes that means delaying treatment until the situation is properly understood.
Why being upfront matters
These are not arbitrary rules. They are safety boundaries.
When we say “not today,” it is rarely a hard no. It is usually a decision about timing, risk, and protecting your long-term outcome.
If you are ever unsure what is relevant, disclose it. Accurate information is what allows appropriate planning and safer care.
At The Manse, caution is not hesitation. It is clinical responsibility.